HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969,435 | +27.1% | 10,822 | +20.8% | 0.00% | +33.3% |
| Q2 2023 | $762,599 | +418.8% | 8,957 | +298.1% | 0.00% | +200.0% |
| Q2 2022 | $147,000 | -0.7% | 2,250 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $148,000 | +59.1% | 2,335 | +33.4% | 0.00% | 0.0% |
| Q4 2021 | $93,000 | -38.8% | 1,750 | -18.8% | 0.00% | 0.0% |
| Q3 2021 | $152,000 | +10.9% | 2,155 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | -38.6% | 2,050 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $223,000 | +1293.8% | 2,010 | +1388.9% | 0.00% | – |
| Q4 2020 | $16,000 | +33.3% | 135 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | +500.0% | 135 | +440.0% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |